Curing Sickle cell Disease with CRISPR-Cas9 genome editing

• Post author:
• Post published:June 9, 2025
• Post category:

Translational Candidate The principal objective of this program is to bring a Cas9-based gene editing cure for sickle cell disease to the pre-IND stage of development. Area of Impact The…

Continue ReadingCuring Sickle cell Disease with CRISPR-Cas9 genome editing

Curing Sickle cell Disease with CRISPR-Cas9 genome editing

• Post author:
• Post published:June 9, 2025
• Post category:

Translational Candidate The principal objective of this program is to bring a Cas9-based gene editing cure for sickle cell disease to the pre-IND stage of development. Area of Impact The…

Continue ReadingCuring Sickle cell Disease with CRISPR-Cas9 genome editing

Cellular Immune Tolerance Symposium

• Post author:
• Post published:June 9, 2025
• Post category:

Continue ReadingCellular Immune Tolerance Symposium

62nd Midwinter Conference of Immunologists

• Post author:
• Post published:June 9, 2025
• Post category:

Continue Reading62nd Midwinter Conference of Immunologists

Cellular Immune Tolerance Symposium

• Post author:
• Post published:June 9, 2025
• Post category:

Continue ReadingCellular Immune Tolerance Symposium

15th International Cord Blood Sympsium

• Post author:
• Post published:June 9, 2025
• Post category:

Continue Reading15th International Cord Blood Sympsium

14th International Cord Blood Symposium: Give Life Twice

• Post author:
• Post published:June 9, 2025
• Post category:

Continue Reading14th International Cord Blood Symposium: Give Life Twice

Drug Discovery & Stem Cell Models for Cardiovascular Disease Conference

• Post author:
• Post published:June 9, 2025
• Post category:

Continue ReadingDrug Discovery & Stem Cell Models for Cardiovascular Disease Conference

International Society for Experimental Hematology, 45th Annual Scientific Meeting

• Post author:
• Post published:June 9, 2025
• Post category:

Continue ReadingInternational Society for Experimental Hematology, 45th Annual Scientific Meeting

Gene Therapy for Artemis-Deficient Severe Combined Immunodeficiency Using a Self-Inactivating Lentiviral Vector

• Post author:
• Post published:June 9, 2025
• Post category:

Continue ReadingGene Therapy for Artemis-Deficient Severe Combined Immunodeficiency Using a Self-Inactivating Lentiviral Vector